New company Liminatus Pharma Inc to develop three cancer treatments
Clinical-stage biopharma company Liminatus Pharma LLC and Iris Acquisition Corp, a publicly traded special purpose…
December 5, 2022 - 3 minutes
South Korea
MaxCyte and Curamys sign cell and gene therapies agreement
MaxCyte, Inc. and Curamys have announced the signing of a strategic platform license. MaxCyte is…
December 5, 2022 - 2 minutes
Adalta and GPCR Therapeutics to collaborate on novel cancer treatments
AdAlta Limited and GPCR Therapeutics Inc, are set to collaborate to evaluate AdAlta’s CXCR4 inhibiting…
October 13, 2022 - 4 minutes
The biggest private biotech investments in August 2022
The healthcare-focused companies Orna Therapeutics, F2G and Sironax bagged the biggest biotech investments in August…
September 7, 2022 - 3 minutes
Stem cell therapy to be used in treatment of long COVID by Panacell Biotech
A South Korean biotech company says it will use natural killer (NK) cells, exosomes and…
August 10, 2022 - 3 minutes
IVI and Moderna sign MOU for vaccine R&D
The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and…
July 20, 2022 - 2 minutes
SK Bioscience signs deal with Novavax to manufacture COVID-19 vaccine
South Korean company SK Bioscience has extended its partnership with Novavax, Inc., a U.S. biotechnology…
July 19, 2022 - 2 minutes
GenScript ProBio enters strategic partnerships with two South Korean biotechs
GenScript ProBio, the CDMO segment of the leading biotech GenScript, has entered into a strategic…
July 14, 2022 - 3 minutes
Legochem Bioscience signs agreement with Glycotope to develop cancer drug
A company from South Korea has signed a research collaboration and license agreement with a…
July 12, 2022 - 3 minutes
